immunotherapy

Pages Tagged with "Immunotherapy"

New hope for cervical cancer patients
When Luzmila Salazar learned she had cervical cancer, she felt like her life was crumbling around her. “It was the worst thing I’d ever heard,” said the 43-year-old mother of...
Teamwork trounces stage 4 lung cancer
John S. Howell likes to talk about his good fortune. “I feel like the luckiest guy in the world,” he’ll say, right at the start of a conversation. Five minutes...
Third treatment’s the charm for lymphoma patient
When postal worker Juan Yee was told that his non-Hodgkin’s lymphoma had relapsed for a second time in 2018, he was ready to let nature take its course.  “I couldn’t...
City of Hope-led trial leads to U.S. Food and Drug Administration’s approval of a first of its kind bispecific antibody
CONTACT Letisia Marquez 626-476-7593 lemarquez@coh.org Mosunetuzumab treats people with relapsed or refractory follicular lymphoma, the most common slow-growing form of non-Hodgkin’s lymphoma LOS ANGELES — A trial led by City...
A trial that failed — and why it’s big news
Usually we write about successful trials that introduce new, advanced treatments. This article, though, is about a trial that failed — but a failure that was so significant, it was...
City of Hope Researcher Identifies Effective Combination Immunotherapy for Subgroup of Patients With Metastatic Colorectal Cancer
CONTACT Zen Logsdon 626-409-9367zlogsdon@coh.org The new data is a foundational step to debunking the perception that immunotherapy is not effective in treating advanced colorectal cancer patients with a biomarker...
Delivering CAR T cell target CD19 onto the surface of solid tumors with a genetically engineered oncolytic virus
Overcoming CAR T cell therapy limitations to treat solid tumor cancers By genetically engineering a tumor-selective oncolytic virus to deliver the surface antigen CD19 for expression on solid tumor cells...